Skip to content
Lower risk Medical device recall · FDA · Published March 2, 2023

Stryker SafeLight Fiber Optic Cable Recall: Light Output Issues May Delay Procedures

Stryker recalls specific SafeLight fiber optic cables due to potential light output issues that could delay medical procedures. Affected units include clear and gray 5mm x 10ft cables with certain reference numbers.

🇺🇸 FDA recall #Z-1474-2023Medical deviceStryker ›
Take action

Contact the company

Recalling firmStryker Corporation5900 Optical Ct · San Jose, CA 95138-1400
✎ GovInfoNow plain-language explainer

Stryker is recalling specific SafeLight fiber optic cables that may cause light output problems, potentially delaying medical procedures. This recall affects certain clear and gray cables sold with specific reference numbers. Read more at govinfonow.com/recall/58795-stryker-safelight-fiber-optic-cable-recall-light-output-issues-may.

Source Summary by GovInfoNow · govinfonow.com/recall/58795-stryker-safelight-fiber-optic-cable-recall-light-output-issues-may · Updated August 18, 2026 · FDA enforcement record: FDA #Z-1474-2023

Cite this page

“Stryker SafeLight Fiber Optic Cable Recall: Light Output Issues May Delay Procedures.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/58795-stryker-safelight-fiber-optic-cable-recall-light-output-issues-may. Based on FDA recall #Z-1474-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1474-2023%22&limit=1).

The FDA announced on March 2, 2023, that Stryker Corporation is recalling SafeLight Fiber Optic Cables due to insufficient epoxy causing light output issues. Owners should contact the company for a replacement.

How to tell if you have it

  • Brand: Stryker
  • Product: SafeLight Fiber Optic Cable: Clear, 5MM X 10FT 3.05M, REF: 0233-050-100
  • Product: SafeLight Fiber Optic Cable: Gray, 5MM X 10FT 3.05M, REF: 0233-050-200
  • Lot codes for REF 0233-050-100: 159190 through 159218, 164764 through 164822, 168940 through 168981, 168987
  • Lot codes for REF 0233-050-200: 158865, 158868, 158869, 158872, 158874, 158875, 158878, 158884, 165446, 165448, 165451, 165457 through 165459, 165461, 165462, 165464, 168909 through 168921, 168923 through 168928
  • Units affected: 5,228

The hazard

The fiber optic cables were assembled with not enough epoxy on the proximal end, creating light output issues. This defect could cause a clinical delay or procedure being converted to open.

Context

GovInfoNow's records show Stryker Corporation has 34 other recalls on record since 2017-11-17. Other recent recalls of similar products include Stryker Ahto Dual Spike Tube Set Leaks During Use (2026-06-08), Stryker Neptune Smart Docking Station Recall: Electrical Shock Risk (2026-05-06), and Stryker FluidSmart Urology Tube Set Recall: Nonconforming Products Distributed (2026-04-09). Other recent recalls of similar products include Stryker CHROMOPHARE Softlit Ring Surgical Light Recall: Ceiling Support Risk (2026-02-23), Beaver-Visitec OME6000U Laser System Recall: USB Cable Manufacturing Issue (2025-12-05), and Philips Azurion System Recall: Cable Hose Carriers May Loosen Over Time (2026-03-31).

How to tell if you have this one

Check for clear or gray 5mm x 10ft cables with reference numbers starting with 0233-050-100 or 0233-050-200. The specific reference numbers listed in the recall include many sequential numbers.

  • Brand
    Stryker
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify if your cable matches the described clear or gray 5mm x 10ft size with the reference numbers listed in the recall.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 49 states.

Alaska: named in the noticeAKMaine: nationwideMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide - US Nationwide distribution including in the states of PA, MS, IL, OH, CA, TX, MO, IN, KS, OK, MT, MA, NE, AZ, NV, NJ, IA, WV, MD, KY, FL, NM, NY, CO, WA, NC, VA, LA, ND, WY, HI SC, UT, OR, SD, AR, TN, AK, CT, GA, ID, VT, NH,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: Mar 2, 202312. FDA classified it Class II: Apr 28, 202323. Published in FDA’s Enforcement Report: May 10, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1474-2023 (March 2, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1474-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA